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The sequences of the cDNAs for the mitochondrial
translational elongation factor Ts (EF-TsDlt ) from bovine
and human liver have been obtained. The deduced
amino acid sequence of bovine liver EF-Tslnt is 338 res-
idues in length and includes a 55-amino acid signal pep-
tide and a mature protein of 283 residues. The sequence
of the mature form of bovine EF-Tslnt is 91% identical to
that of human EF-Tslnt and 29% identical to Escherichia
coli EF-Ts. Southern analysis indicates that there are
two genes for EF-TSlnt in bovine liver chromosomal DNA.
A 224-base pair intron is located near the 5' -end of at
least one of these genes. Northern analysis using a hu-
man multiple tissue blot indicates that EF-Tslnt is ex-
pressed in all tissues, with the highest levels of expres-
sion in skeletal muscle, liver, and kidney. Both the
mature and precursor forms of bovine liver EF-TSm t
have been expressed in E. coli as histidine-tagged pro-
teins. The mature form ofEF-Tslnt forms a complex with
E. coli elongation factor Tu. This complex is active in
poly(U)-directed polymerization of phenylalanine. The
precursor form is expressed as a 42-kDa protein, which
is rapidly degraded in the cell.
In Escherichia coli, elongation factor Tu (EF-Tu)l facilitates
the binding of aminoacyl-tRNA to the ribosome during the
elongation cycle of protein biosynthesis (1). Following A-site
binding of the correct aminoacyl-tRNA, EF-Tu catalyzes the
hydrolysis of GTP, and EF-Tu'GDP is released from the ribo-
some. Elongation factor Ts (EF-Ts) catalyzes the nucleotide
exchange reaction promoting the formation ofEF-Tu'GTP from
EF-Tu'GDP (2). The guanine nucleotide exchange reaction oc-
curs through the formation of an intermediate EF-Tu·Ts com-
plex (3). In contrast to E. coli, during the elongation cycle of
protein synthesis in Thermus thermophilus, a dimeric form of
EF-Ts binds two molecules of EF-Tu, forming an (EF-Tu·EF-
TS)2 structure, which is extremely stable and cannot be disso-
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ciated in the absence of protein-denaturing reagents (4). In this
organism, GDP present in the EF-Tu'GDP complex is thought
to exchange directly with GTP present in the (EF-Tu·EF-
Ts·GTP)2 dimer. Mammalian mitochondrial EF-Tu and EF-Ts
(EF-TUmt and EF-Tsmt) have been purified as a tightly associ-
ated complex (EF-Tu·Tsmt) from bovine liver (5, 6). The EF-
TU'Tsmt complex is very stable and cannot be dissociated even
in the presence of high concentrations of guanine nucleotides.
In this respect, the mitochondrial factors differ significantly
from the corresponding E. coli factors and show some resem-
blance to thermophilic EF-Tu and EF-Ts.
The stability of the EF-Tu'EF-Ts complex is thought to be
determined largely by the nature of the EF-Ts component. For
example, EF-Ts from thermophilic bacteria forms strong com-
plexes with E. coli EF-Tu, whereas E. coli EF-Ts produces only
weak complexes with thermophilic EF-Tu (7). In addition, chlo-
roplast EF-Ts from Euglena gracilis forms a tighter complex
with E. coli and chloroplast EF-Tu than does the E. coli factor
(8). It is not clear what features ofEF-Ts modulate the strength
of its interaction with EF-Tu.
The genes for EF-Ts from several prokaryotes have been
cloned and sequenced, as has the gene for chloroplast EF-Ts
from the thermophilic red algae Galdieria sulphuraria. In gen-
eral, the overall sequence for EF-Ts is far less conserved than
the sequence for EF-Tu, but there is some conservation located
in the NH2-terminal one-third of the protein. In this work,
cDNAs encoding EF-TSmt have been cloned and sequenced from
both bovine and human liver. In addition, bovine liver EF-Tsmt
has been expressed in E. coli.
EXPERIMENTAL PROCEDURES
Peptide Sequence Analysis ofBovine Liver EF-Tsmt-EF-Tu·Tsmt was
purified as described (5). The EF-Tumt and EF-Tsmt components were
separated by reverse-phase high performance liquid chromatography
using a Brownlee RP300 column (2.1 x 100 mm) with a linear gradient
of acetonitrile, 0.1% trifluoroacetic acid (20-64%) over 60 min. The
fraction identified as EF-TSmt was dried, dissolved in 8 M urea, and
incubated at 50°C for 30 min. The solution was diluted to 4 Murea with
0.2 M Tris-HCI, pH 8.5. Sequence-grade endoproteinase Lys-C was
added (5 J.Lg), and the sample was incubated at 37°C for 20 h. The
resultant peptides were separated on a Brownlee RP300 column (1.0 x
250 mm) with a linear gradient of acetonitrile, 0.1% trifluoroacetic acid
(8-64%) over 90 min. The prominent peaks were sequenced on an
Applied Biosystems 477A liquid-pulse sequencer connected to an Ap-
plied Biosystems 120A phenylthiohydantoin analyzer.
Synthesis of EF-Tsmt-specific cDNA and PCR Amplification-Total
RNA was extracted from bovine liver by the guanidinium thiocyanate
procedure (9). Poly(A)+ RNA was purified by oligo(dT)-cellulose chro-
matography (10). Single-stranded cDNAs were synthesized by reverse
transcription of 5 J.Lg of mRNA using primer 3 or 4 (see Table I) or
primer NS (GGAATTCCCTGCCTGTTTGAGATCCCCGC; the under-
lined sequence represents an EcoRI adaptor). Bovine liver chromosomal
DNA was prepared as described (11).
PCR amplification reaction mixtures (l00 J.LI) contained 0.2 mM
dNTPs, 2.5 units of Taq DNA polymerase, 50 pmol of the appropriate
primers, the buffer system purchased with Taq DNA polymerase (Pro-
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a N is A, G, T, or C; I is inosine; Y is T or C; R is G or A; X is I or C; and H is A, C, or T.
b Underlined sequences were used for designing degenerate oligonucleotide primers.
C Represents the BamHI linker: 5'-CGGGATCCCG-3'.
d Represents the EcoRI linker: 5'-GGAATTCC-3'.
mega), and either 1jJ-g of bovine liver chromosomal DNA or an aliquot
of the specifically primed eDNA. When the eDNA was used as template,
the first five cycles were done at 94 DC for 1 min (denaturation), 56 DC
for 1.5 min (annealing), and 72 DC for 2 min (polymerization). For the
remaining 35 cycles, annealing was carried out at 61 DC. When chro-
mosomal DNA was used as template, primer annealing was done at
50 DC during the first five cycles and at 55 DC in the 35 remaining cycles.
In the last cycle, the reaction time at 72 DC was extended to 5 min to
allow completion of chains.
Nested PCRs involving a second or third round of amplification were
carried out as described above, except that they contained 1 jJ-l of the
reaction mixture obtained from the previous round of PCR as the
template. The reaction mixtures were analyzed on 1.5% agarose or 3%
NuSieve GTG-agarose gels. Specific bands were identified by ethidium
bromide staining and eluted from the gel using a Geneclean or Mermaid
kit (BIO 101, Inc.).
Screening eDNA Libraries-Approximately 5 x 106 plaques from two
bovine liver libraries (Stratagene) and 2 X 106 plaques from a human
liver eDNA library (CLONTECH) were screened by hybridization with
a bovine liver EF-Ts=t eDNA probe obtained by PCR amplification and
labeled using random priming (12). Hybridizations with bovine liver
libraries were carried out at 65 DC, while hybridization with the human
library was done at 55 DC. Positive plaques were replated until purified,
and the pBluescript SK( -) phagemid clones were excised according to
the manufacturer's instructions (Stratagene).
5' -Rapid Amplification of eDNA Ends (5' -RACE)-8ingle-stranded
eDNA was synthesized as described above using the reverse primer NS.
A poly(dA) tail was added to this eDNA by terminal transferase. This
eDNA was used as template for 5'-RACE-PCR (13). A specific PCR
product, -260 bp, was obtained, and two BamHI fragments from it
were cloned into pTZ18R.
DNA Sequencing-EF-Ts=t clones were sequenced by the
dideoxynucleotide chain termination method (14) and subjected to au-
tosequencing in the University of North Carolina DNA Sequencing
Facility. All clones were sequenced completely in both directions. Anal-
ysis of the sequence was done with Genetics Computer Group sequence
analysis programs running on a VAX computer. Single-stranded 5'-
RACE products were sequenced after two rounds of nested PCR. The
single-stranded DNA was generated in the second round of PCR by
using one primer in a 50-fold molar excess over the other primer.
Northern and Southern Analyses-Northern analysis of polyrA)"
RNA was performed using 1% agarose gels run in the presence of 1 M
glyoxal and 50% dimethyl sulfoxide as described (15). Bovine chromo-
somal DNA (30 jJ-g) was digested with an optimal amount of the indi-
cated restriction enzyme. Digests were run on 1.5% agarose gels at 60
V for 19 h. Nucleic acids were transferred to Zeta-Probe blotting mem-
branes as recommended by the manufacturer (Bio-Rad), and blots were
probed as indicated.
Expression and Purification of Mature and Precursor Forms of Bo-
vine Liver EF-Ts~t-PCR was used to add an Ndel cutting site to the
5' -end and an Xhol cutting site to the 3' -end of the bovine liver eDNA
encoding the precursor form ofEF-Ts=t and to the portion of the eDNA
encoding the mature form of EF-Ts=t. These cDNAs were then cloned
into pET24c( +). E. coli BL2l(DE3) was used as the host for expression.
Purification of the mature and precursor forms under denaturing con-
ditions was performed using nickel-nitrilo-triacetic acid (Ni-NTA) affin-
ity chromatography as described by QIAGEN Inc. For the large-scale
purification of the mature and precursor forms under native conditions,
expression was induced by exposure of cells (1.0-1.2 A 6 0 0 units/ml) to
0.025 mM IPTG. Cells were collected after 1 h of induction and lysed by
grinding with two times the cell weight of alumina for 20 min on ice.
The cell paste was resuspended in 4 volumes of buffer containing 50 mM
Tris-HCl, pH 7.6, 60 mMKCl, 7 mMMgCI 2 , 7 mM l3-mercaptoethanol, 0.1
mM phenylmethylsulfonyl fluoride, and 10% glycerol. Alumina was
removed by centrifugation at 11,000 x g at 4 DC for 15 min. The
supernatant was collected and incubated with DNase I (5 jJ-g/ml)for 15
min on ice. The extract was then subjected to centrifugation at 15,000
x g for 30 min. Ni-NTA resin (0.4 ml ofa 50% slurry) equilibrated in the
same buffer was added to the extract for each 1 liter of original culture.
This slurry was shaken at 4 DC for 1 h. The Ni-NTA resin was collected
by centrifugation at 15,000 x g for 10 min, rinsed with 35 ml of wash
buffer (50 mMTris-HCl, pH 7.6, 1 MNH4Cl, 5 mM l3-mercaptoethanol, 10
mM imidazole, and 10% glycerol), poured into a small column, and
washed with an additional 60 ml of wash buffer. Protein was eluted
from the resin using three aliquots (1 ml each) of elution buffer (50 mM
Tris-HCl, pH 7.6, 40 mM KCl, 5 mM l3-mercaptoethanol, 0.15 M imidaz-
ole, and 10% glycerol). The eluted protein was dialyzed immediately
against a 100-fold excess of buffer containing 20 mM HepesIKOH, pH
7.0,40 mM KCl, 1 mM MgCI 2 , 0.1 mM EDTA, and 10% glycerol.
Assays and Western Analysis-The protein concentrations were de-
termined by the Micro-Bradford method (Bio-Rad). The activity of the
complex containing E. coli EF-Tu and EF-Ts=t (E. coli EF-Tu·EF-Ts=t)
was measured by its ability to catalyze the poly(U)-directed polymeri-
zation of phenylalanine on E. coli ribosomes (5, 6). One unit is defined
as the incorporation of 1 pmol of [14C]Phe into polypeptide at 37 DC
using a 30-min incubation. Polyclonal antibodies against EF-Tu'EF-
TS=t were produced by Pel-Freez Biologicals (Rogers, AK)? Western
blotting was done by using the enhanced chemiluminescent detection
system of Amersham Corp.
RESULTS AND DISCUSSION
Cloning of Bovine and Human Liver EF-Tsm t cDNAs-EF-
TSrn t is the product of a nuclear gene in mammals. To obtain
cDNA clones of this factor, it was necessary to obtain partial
peptide sequence information. The EF-Tu·Tsrn t complex was
dissociated, and the two factors were separated by reverse-
phase high performance liquid chromatography. EF-Tsrn t was
subjected to NH2-terminal Edman degradation and to internal
peptide sequence analysis following digestion with endopro-
teinase Lys-C. The sequences of six peptides ranging in size
from 9 to 26 residues including the NH 2-terminal peptide were
obtained (Table I). Several of the peptides have only a low
sequence identity to the sequences for the corresponding pro-
karyotic factors, and except for the NH2-terminal peptide, their
relative positions could not be predicted. Degenerate oligonu-
cleotide primers were designed from these sequences. Forward
primers Np-1 and 1 were derived from the NH2-terminal pep-
tide, and their relative positions with respect to each other
were known exactly (Fig. 1). Reverse primers 3 and 4 were
predicted to be located either in the middle or the COOH-
terminal region of EF-Ts rn t • The positions of primers 3 and 4
relative to each other could not be predicted. Hence, two groups
of nested reverse transcriptase-PCRs were carried out (Fig. 1).
Two specific cDNAs were synthesized, one using primer 3
(cDNA3) and the other using primer 4 (cDNA4). In the first
round ofPCR, the primer used for cDNA synthesis was used in
combination with primer Np-1 derived from the NH2-terminal
2 V. Woriax and L. Spremulli, manuscript in preparation.
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sequence. No specific bands were visible after the first round of
PCR in either group. A second round of PCR was performed
using the product of cDNA3 and primers Np-1 and 4. No spe-
cific bands could be observed after this second round of PCR,
suggesting that primer 3 lies to the 5'-side of primer 4. In
contrast, a very strong band of -650 bp could be observed after
the second round of PCR using the product of the first round of
PCR derived from cDNA4 with primers 3 and Np-1 (Fig. 1).
This observation confirms the idea that primer 3 lies to the
5' -side of primer 4, allowing the nested PCR to succeed. To
further confirm the identity of the 650-bp product, this frag-
ment was amplified using primers 3 and primer 1. This reac-
tion gave a product of -600 bp, ~60 bp shorter than the
starting DNA. This size difference corresponds to the distance
between primers Np-1 and 1. The 650-bp product was cloned
into vector pTZ18R and sequenced. The deduced amino acid
sequence of this fragment contained five of the peptides ob-
tained by sequence analysis, confirming that this fragment is
indeed a partial cDNA coding for bovine liver EF-Tsrnt •
Bovine liver AZap II and AMAX-1 cDNA libraries were
screened for additional portions of the EF-Tsrnt cDNA. Three
positive plaques were isolated from the AZap II cDNA library,
and the pBluescript plasmids carrying the cDNA inserts of
interest were excised in vivo. DNA sequence analysis indicated
that these clones encompassed the entire 3 '-region of the EF-
TSrnt cDNA, including the poly(A) tail. Five clones were isolated
in a similar manner from the AMAX-1 cDNA library. They
contained inserts of -135 bp from the middle of the EF-Tsm t
coding sequence. None of eight clones isolated contained the
5'-region of the bovine liver EF-Tsm t cDNA, and all of the
inserts had the same 5' -end. Subsequent analysis of the se-
quence of the EF-Tsm t cDNA indicated that there is a G:C-rich
region just upstream of this position. Presumably, secondary
structure in the mRNA resulted in a strong stop for reverse
transcriptase during cDNA synthesis. To obtain the sequences
from the 5 '-end of the EF-Tsm t cDNA, 5'-RACE-PCR was car-
ried out (13). This approach allowed the cloning of an addi-
tional176 bp from the 5'-end of the EF-Tsrnt cDNA.
Analysis of the cDNA clones described above provided 1297
bp of sequence including the polyt.A) tail and encompassing the
entire coding region (Fig. 2). The size of the cDNA obtained
corresponds well to the size estimated for the mRNA by North-
ern analysis (data not shown). The long open reading frame
codes for the entire EF-Tsm t polypeptide, including a 55-amino
acid mitochondrial localization signal and a mature protein of
283 amino acids. The cDNA sequence indicates that bovine
liver EF-Tsm t has a very short 5'-untranslated region (18 bp
long). Although few eukaryotic cytoplasmic mRNAs have
leader regions as short as 18 nucleotides, work by Kozak (16-
18) indicates that a leader of this length is generally sufficient
to allow initiation. It is possible that all of the clones obtained
by 5' -RACE-PCR are shorter than the actual mRNA, reflecting
a strong barrier to reverse transcriptase at this position. How-
ever, 27 clones obtained by 5 '-RACE-PCR all terminated
within this region. The initiation codon (designated position
+ 1) is preceded by an A residue at position -3 and followed by
a T residue at position +4. Analysis of numerous translational
start sites indicates that the consensus sequence has a purine
at position -3 and a G residue at position +4 (19). The 3'-
untranslated region is 190 bp in length and contains a polya-
denylation signal (AAUAAA) 16 nucleotides before the polyrA)
tail. An analysis of the encoded amino acid sequence is pro-
vided below.
The bovine liver cDNA was used as a probe to screen a
human liver AZap II library. Two of the 10 positive clones
obtained had inserts of ~ 1 kilobases, including a polytA) tail.
These two clones included the entire coding region for the
mature form of bovine liver EF-Tsrnt and a portion of the
mitochondrial import signal (Fig. 2).
Sequence Analysis of Mammalian EF-Tsm t- NH2-terminal
sequence analysis indicates that the mature form of bovine
liver EF-Tsrnt begins with Ser-56 in the long open reading
frame (Fig. 2). The mitochondrial import signal for EF-Tsrnt is
thus 55 residues long. Mitochondrial import sequences are not
highly conserved in primary sequence. However, they generally
lack acidic residues, are enriched in basic and hydroxylated
amino acids, and can form an amphiphilic a-helix or ,B-sheet.
The transit peptide for bovine EF-Tsm t lacks acidic residues,
but is not particularly enriched in either basic or hydroxylated
residues. It does not appear to be able to form an amphiphilic
a-helix or ,B-sheet. At least two different pathways are believed
to be involved in the processing of proteins imported into mi-
tochondria (20). One pathway uses a single mitochondrial proc-
essing peptidase that recognizes Arg at position -2 relative to
the processing site (20). The precursor for bovine liver EF-Tsm t
does not appear to fit into this group. A second pathway in-
volves sequential cleavage by two proteases. Proteins processed
by this pathway generally have Arg at position -10, a hydro-
phobic residue at position -8, and Gly, Ser, or Thr at position
-5 relative to the cut site. The precursor for bovine liver
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FIG. 2. Primary sequences ofbovine
and human liver EF·Tsm t cDNAs. A,
the nucleotide sequence of the bovine
liver EF-Ts=t cDNA is shown along with
the amino acid sequence of EF-Ts=t be-
ginning with the first ATG codon. Under-
lined sequences indicate peptides ob-
tained from protein sequencing. *8 is the
NH2 terminus of the mature form of bo-
vine liver EF-Ts=t. The double exclama-
tion points indicate the position of the
intron in the bovine liver EF-Ts=t gene.
The amino acid residues under the se-
quence for bovine liver EF-TS=t indicate
the differences in this sequence from hu-
man liver EF-Ts=t. The human liver
cDNA lacks sequence information from
the 5' -end of the mRNA including a por-
tion of the signal peptide and begins with
the alanine designated **A. The mature
form of human liver EF-TS=t probably be-
gins at the same position as the bovine
liver EF-Ts=t. B, shown is the sequence of
the intron in the bovine liver EF-Ts=t
genes. This intron is located between po-
sitions 99 and 100 of the eDNA.
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CTGGTCCCTTGCTGCCTTCCTTGCAGGCCGGGCTCCCTCTGCTTCAGTCGCCCCAGCAGTGGCATACTTTTCACTCTGGATCCTGGCTGT 163
G P L L P S L Q A G L P L L Q s P Q Q W H T F H S G S W L S
**A R V Y A G P R L S A
CCTCGGCTTCCAGCAAGGAGCTTCTCATGAAGCTGCGGAGGAAAACGGGCTACTCCTTTATAAACTGCAAGAAAGCCCTGGAGACTTGTG 253
*5 ASS K ELL M K L R R K T G Y S FIN C K K ALE T C G
V
GCGGGGATCTCAAACAGGCAGAGAGCTGGCTCCATAAGCAGGCCCAGAAGGAGGGCTGGAGTAAAGCTGCTAGGCTCCATGGGAGGAAGA 343
G D L K Q A E S W L H K Q A Q KEG W S K A A R L H G R K T
I E K Q
CCAAAGAAGGTCTGATTGGGCTGCTGCAGGAAGGAGACACAACTGTGTTAGTAGAGGTGAACTGTGAGACAGATTTTGTTTCCAGAAATT 433
KEG L I G L L Q E G D T T V L V E V N C E T D F V S R N L
N
TAAAATTTCAACAGTTGGTCCAGCAAGTAGCCCTGGGAACCCTGTTGCATTGTCAGAACTTAAAGGATCAACTCTCCACATACAGTAAAG 523
K F 0 0 L V 0 0 V A L G T L L H CON L K 0 Q L STY S K G
L MM T P A
GCTTCTTGAATTCCTCTGAGCTCTCTGAACTTCCAGCAGGACCTGAGAGAGAGGGTTCTCTCAAGGATCAGCTGGCTTTAGCAATTGGGA 613
F L N SSE L S E L P A G PER E G S L K DOL A L A I G K
G D
AACTGGGAGAAAACATGATTCTGAAACGGGCTGCATGGGTGAAGGTGCCAGCTGGTTTCTATGTTGGCTCTTATGTCCATGGGGCAATGC 703
L G E N MIL K R A A W V K V P A G F Y V G S Y V H GAM H
S Q
ACAGCCCCTCACTCCACAACCTGGTGCTGGGGAAGTATGGGGCCCTGGTCATCTGCGAGACGTCAGAGTTGAAGGCAAACCTCGCAGACC 793
S P S L H N L V L G K Y GAL V ICE T S ELK A N LAD L
K Q T E V
TTGGCCGCCGCCTTGGGCAGCACGTGGTAGGCATGGCTCCCCTCTCTGTTGGCTCCCTGGACGACGAGCCCGGGGGAGAGGCGGAAACCA 883
G R R L G Q H V V G MAP L S V G S L DOE P G G E A E T K
AGATGCTGTCCCAGCCATACTTGCTGGACCCTTCCATCACACTGGGACAGTACGTGCAGCCCCATGGGGTGTCCGTCGTAGACTTTGTGC 973
M L SOP Y L L D PSI T L GOY V 0 P H G Y S v v 0 F V R
Q
GGTTTGAGTGTGGAGAAGGTGAAGACGCAGCAGACGCCGAATAGATCCCAGAGAATTTGGGCCCAGGAGGACATGTTTATTCTTAACCCT 1063








EF-Tsm t has His at position -10, Phe at position -8, and Gly
at position -5 and may possibly be processed by this two-step
pathway.
The mature form of bovine EF-TSm t is 283 amino acids in
length (Fig. 2) and has a molecular mass of 30,739 Da. The
mature form of human liver EF-Tsm t also appears to have 283
residues. The two mammalian EF-Tsm t sequences are 91%
identical (Table II). The sequence of EF-Ts from three pro-
karyotes (E. coli, Spiroplasma citri, and Spirulina platensis),
one chloroplast EF-Ts sequence (G. sulphuraria), and several
eukaryotic EF-1f3-y8 sequences have been reported (21-25). The
{3- and 8-subunits of the cytoplasmic factor have both been
reported to function as nucleotide exchange factors (24, 25).
The bacterial factors are -250-300 residues in length, similar
to the size of the mammalian mitochondrial factors. The one
known gene for chloroplast EF-Ts encodes a protein of 199
residues, although it is unclear whether this gene actually
encodes a functional product (23). The only chloroplast EF-Ts
studied at the protein level to date is from E. gracilis (26) and
appears to be a monomer of 62 kDa, considerably larger that
any of the corresponding factors known. The {3- and 8-subunits
of the cytoplasmic factor EF-1 are 227 and 265 residues in
length, respectively (24, 25). A comparison of the sequences of
these nucleotide exchange factors (Table II) indicates that
mammalian EF-Tsm t is 27-35% identical to the corresponding
prokaryotic and chloroplast factors, but <21% identical to ei-
ther the {3- or 8-subunit of EF-1.
The alignment of the sequences of EF-Ts from prokaryotes,
chloroplasts, and mammalian mitochondria (Fig. 3) indicates
that conserved regions are clustered in the NH 2-terminal one-
third of the protein. The complete conservation of 22 residues
in these factors is observed, with 20 of these amino acids being
located within the first 90 residues. The longest stretch of
completely conserved residues is 5 amino acids long. There is
also a conserved stretch of 10 residues present if conservative
substitutions are taken into account. Little information is
available On the regions of EF-Ts that are important for the
nucleotide exchange activity of this factor. The sequence align-
ment presented in Fig. 3 and the observation that EF-Tsm t will
promote GDP exchange with E. coli EF-Tu suggest that the
NH 2-terminal one-third of the protein may playa particularly
important role in this process.
Analysis of the EF-Tsm t Genes-For determination of the
number of copies of the gene encoding bovine liver EF-Tsm t , a
Southern blot of total DNA digested with EcoRI, BamHI, Hin-
dIll, and BglIl, respectively, was probed using nucleotides
177-1182 as a probe (Fig. 4). This region was selected as a probe
because peR analysis of genomic DNA and the cDNA indicated
that no introns were present in this region of the gene (data not
shown). EcoRI cuts the probe once, while the other three en-
zymes do not have a cutting site in the probe. As indicated in
Fig. 4, EcoRI digestion resulted in the appearance of four
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TABLE II
Identity of the known EF-Ts and EF-l{38 amino acid sequences from various organisms
Sequence comparisons were done with the BESTFIT program in the Genetics Computer Group software package.
E. coli" s. citri S. platensis G. sulfuraria BLTs HLTs EF-lf3 EF-18
% % % % % % % %
E. coli 100
S. citri 44 100
S. platensis 54 41 100
G. sulfuraria 46 39 44 100
BLTs 29 29 35 27 100
HLTs 29 30 35 29 91 100
EF-1{3 16 21 17 20 16 19 100
EF-18 16 17 20 17 16 21 58 100
"The designations used are as follows: E. coli, E. coli EF-Ts; S. citri, S. citri EF-Ts; S. platensis, S. platensis EF-Ts; G. sulfuraria, G. sulfuraria
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FIG. 3. Comparison of the amino acid sequences ofEF-Ts from different organisms. The alignment of the sequences was carried out by
using the PILEUP program in the Genetics Computer Group software package. See Footnote a in Table II for definition of the designations used.
bands, while BamHI, HindIlI, and BglII digestion gave two
bands on the Southern blot. These results suggest that two
genes encoding EF-Tsm t exist in bovine chromosomal DNA.
PCR analysis failed to amplify genomic sequences correspond-
ing to the eDNA, suggesting that neither of the genes detected
is a pseudogene (data not shown). It has recently been observed
that there are also two copies of the EF-Tum t gene in bovine
chromosomal DNA.3
An examination of the EF-Tsm t gene for the presence of
intervening sequences was carried out by PCR amplification of
chromosomal DNA using different combinations of oligonucleo-
tide primers designed from the eDNA sequence. This analysis
indicated the presence of an intron near the 5'-end of the
bovine EF-Tsm t genes. The PCR analysis used here suggests
that both genes contain a similarly sized intron. However, this
procedure can only detect relatively small introns, and this
interpretation must be viewed with caution. This intron (224
bp) was cloned and sequenced (Fig. 2B).
Northern Analysis of the EF-Tsm t mRNA in Different Human
Tissues-There are no reports on the expression ofEF-Tsm t in
any mammalian species to date. To investigate the relative
amounts of the EF-Tsm t transcript in different human tissues,
3 V. Woriax, W. Burkhart, and L. Spremulli, manuscript in prepara-
tion.
a multiple tissue Northern blot was analyzed using the full-
length eDNA of EF-Tsm t as a probe. As shown in Fig. 5, EF-
TSm t transcripts of ~ 1200 bases could be observed in all the
human tissues analyzed. Human skeletal muscle had the most
abundant level of transcripts among the tissues tested, fol-
lowed by liver, kidney, and heart. Placenta, brain, pancreas,
and lung had substantially lower levels of the mRNA for EF-
Tsm t . Higher levels of expression were clearly observed in spe-
cialized tissues known to have high demands for energy pro-
duction. Skeletal muscle contains not only the normal 1200-
base mRNA, but also a larger transcript. Lower amounts of this
other transcript are observed in several other tissues. This
transcript may possibly arise from use of an alternative polya-
denylation site (27) or from transcription of the two separate
genes or may represent a cross-hybridizing mRNA.
Expression of the Mature Form and the Precursor ofEF-Tsm t
in E. coli-Both the precursor of bovine liver EF-Tsm t (pre-EF-
Tsm t ) and the mature form of this factor (amino acids 56-338)
were cloned into a pET expression vector. Both constructs carry
a 6-residue histidine tag at the COOH terminus separated from
the normal COOH terminus by a Leu-GIu linker. As indicated
in Fig. 6 (lane 1), little, if any, material corresponding to EF-
TSm t was detectable in extracts of uninduced cells. However,
following IPTG induction, a major band with a molecular mass
of 34 kDa was observed (Fig. 6, lane 2). Western analysis of
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FIG. 6. SDS-PAGE a n d Wester n b lot a nalysis of the ex pressi on
of EF -Ts ~ t . Lanes 1-5, silver-stained SOS -polyacry lami de gels ; lanes
6- 8, Western blot of samples correspond ing to lanes 1-3 using antibod-
ies raised against bovine liver EF-Tu·Tsmt. Lan es 1 and 6, no IPTG
ind uction ; lanes 2 and 7, th e mature form of EF- Tsmt purifie d under
denaturi ng conditions; lanes 3 and 8 , EF -T u' T s ~ t purified from bovine
liver; lane 4, the mature form ofEF-Tsmt puri fied under nondenaturing
conditions ; lane 5, E. coli EF -Tu prepared as described previous ly (5).
Th e positions of protein molecu lar ma ss markers a re shown on th e left .
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F IG . 4. So uthern a nalysis fo r the d e te rmina ti on of t h e number
o f co pies of genes for EF -T s~ t in bovin e DNA . Total DNA from
bovin e liver was digest ed with EcoRI (lane I ), BglII (lane 2 ), HindIII
(lane 3 ), and BamH I (lane 4 ), and th e fragments produced were sepa -
rated by agarose gel electrophor esis as described under "Experimenta l
Procedures." The probe used extended from nucl eotides 177 to 1182 .
The relative positions of size marker s a re indicated (in kilobases (kb)).
Th e weak int en sity of th e sma lle r band in lane 4 is thou ght to be th e




















Comp le x Added, ng
FIG. 7. Act ivi ty of th e E . coli EF -T u ·EF ·Ts~ t co m p lex a n d bo-
v ine li ve r EF .T u ·EF .Ts~ t in poly(U) -d irected p olymerization.
The indicated amounts of EF-Tu 'Tsmt purifi ed from bovine liver (.) or
of the E. coli EF-Tu·Ts mt complex (e) were tested for activity as de-
scribed under "Experimenta l Procedu res."
F IG . 5. Multiple t iss ue No rth ern bl ot analysis of th e EF -Ts~ t
m RNA t ranscribed in d iffer en t h uman tissues . Th e mult iple tissue
Northern blot contained 2 JLg of polytA)" mRNAs from various human
tissues . The blot was hybridized to a probe encompass ing residues
177-1182 of the bovin e liver eDNA. Size s of RNA ma rke rs a re shown on
the left (in kilobases ). Lane 1, heart; lane 2, brain ; lane 3 , placenta ; lane
4, lung; lane 5 , liver; lane 6, ske leta l mu scle; lane 7, kidn ey; lane 8,
pancreas.
samples before and afte r induction (lanes 6 and 7) indicated
that the new band reacted strongly with antibodies ra ised
against bovine EF- Tu 'Ts mt" This observation dem onstrates
that the cells are indeed expressing the bovine mi tochondri al
facto r . Th e expressed EF- Tsmt migrated on SDS-PAGE to a
positi on - 2 kDa larger than that observed wit h EF-Tu·Tsmt
prepared from mi tochond ria (F ig. 6, lanes 2 and 3 ). Th is obse r-
vation is not surpr is ing sinc e there are 9 extra amino aci d
resi dues including the His tag in the expressed form of the
facto r . An exami nation of the effects of induction of EF-Ts mt on
2.4- the growth of the host E . coli cells indicated that the cells
stopped gro wing wit hin 1 h after induction, suggesting that th e
expression of the bovin e mitochond ri al factor is toxic to the
cells. Maxim al levels of induction were obse rved between 1 and
2 h following addit ion of lPTG, and concentrations of lPTG as
low as 25 JLM gave maximal levels of exp ression .
Th e His-tagged form of pre- EF-Tsmt was expressed in E. coli
as a 42-kDa protein . Pre -EF-Ts mt could be observed primarily
in extracts made under den aturing conditions and when induc-
t ion was carried out for only - 30 min . Longer periods of'ind ue-
t ion resul ted in the degr ad a tion of pre-EF-Tsmt (data not
show n ).
When the mature form of EF-Ts mt was pu rifi ed by Ni-NTA
chromatography under nond en aturing conditions and then an-
alyzed by SDS-PAGE (Fig. 6, lane 4 ), a band with a molecular
mass of 44 kDa copu r ified with EF-Tsmt. This band appears to
have a molecula r mass iden tica l to that of E. coli EF -Tu (lane
5 ), indicating that the mi tochond rial factor will form a complex
with bacteri al EF-Tu. Thi s obse rvation is not surpr ising since
EF-Tsmt can promote guanine nucleotide exchange with pro-
karyotic EF-Tu (5).
The ability of th e E. coli EF-Tu ·EF-Tsmt complex to function
in the polyfU j-directed polym eriza t ion of phenylalanin e was
examine d. As shown in Fig. 7, this complex was active in the in
vitro assay. Th e specific activity obtained for the heterologous
complex (140,000 un its/mg) is - 30% of the activity that is
obtained with the homologous EF-Tu·Tsmt complex from bovine
liver. Th e E. coli EF-Tu·EF-Tsmt compl ex func tions catalyti -
cally in the polym eri zat ion assay, wit h - 10 round s of phenyl-
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alanine incorporated into peptide for each complex pres-
ent. A more detailed analysis of the properties of this heterol-
ogous complex is now underway.
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